At the September 11, 2020 board meeting of the Texas State Board of Dental Examiners (Board), Board staff was directed to initiate possible rulemakings for the topic below. This stakeholder meeting will convene on October 5, 2020 via Zoom.
The Board requests stakeholder input on the following topic related to possible rulemaking proceedings:
Benzodiazepine doses, specifically what is acceptable for in office and out of office administration, and existing provisions of the Dental Practice Act and Board rules.
Staff will convene a stakeholder meeting to seek stakeholder input regarding this topic on Monday, October 5, at 10:00 a.m. The physical location of the meeting is William P. Hobby Jr. State Office Building, Tower III, Room 102, at 333 Guadalupe Street, Austin, Texas, 78701. Stakeholders will only be allowed to participate via Zoom.
Staff will post details on the Board’s website closer to the meeting date on how to participate via Zoom and submit comments. The details will be posted here:
Stakeholders may submit informal input by mail to the Board’s General Counsel at 333 Guadalupe Street, Suite 3-800, Austin, Texas, 78701, by fax to (512) 649-2482, or by email to firstname.lastname@example.org. Information regarding Board proceedings and the laws and rules related to dentistry are available at www.tsbde.texas.gov.
Persons who have special communication or other accommodation needs who are planning to attend the stakeholder meeting should contact executive assistant Wendy Richardson, at email@example.com or (512) 305-9332. Arrangements should be made as far in advance as possible.